LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

LifeSignals Group has announced that it has received U.S. Food and Drug Administration 510(k) clearance for the LifeSignals ECG Remote Monitoring Patch platform.

The platform is a wireless remote monitoring system intended for use by healthcare professionals for the continuous collection of electrocardiography and heart rate monitoring in ambulatory, hospital, home and healthcare settings.

View this post on